Record Q2 2026 sales and EBITA were achieved, with strong organic growth in EMEA and APAC, and robust OEM segment performance. Acquisition activity and private label expansion support long-term growth, while leverage remains within target range.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.